The EMA recommended EU approval of Waskyra, a single-dose gene therapy for patients 6 months and older with Wiskott-Aldrich syndrome who lack a suitable HSCT donor....
The European Medicines Agency (EMA) is close to authorizing UCB's new treatment, Bimzelx, for hidradenitis suppurativa. The positive assessment from the Chmp suggests it could be...